Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Article content
As part of the study, researchers will seek to recruit 460 patients at 12 sites, including Ottawa, with conditions such as multiple sclerosis and arthritis.
Cowan, an assistant professor at uOttawa, said she hopes the study will allow researchers to better understand which parts of the immune system are essential in generating an immune response to COVID-19 vaccines. Such information, she said, could help in the design of future vaccines.
• Dr. Angela Crawley, a scientist at The Ottawa Hospital and an assistant professor at uOttawa, is leading a $1.7 million project to expand an earlier study, known as Stop The Spread Ottawa. Launched in October 2020, that study has already recruited more than 1,000 people who tested positive for COVID-19 or faced a high risk of exposure.
How well do COVID-19 vaccines work in people with cancer, globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Extensive Study in Canada to Assess COVID-19 Vaccine Immune globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.